THE PRIMER
SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
Exploring RNA DrugS: Antisense, RNAi, and MicroRNA
RNA-based drug therapy has taken the biotech world by storm, reshaping treatment landscapes with its ability to target “undruggable” areas and provide personalized patient solutions.
Fighting Disease With Breath Biopsies: Lower Risk & Lower Cost
A breath biopsy is a diagnostic method that analyzes the volatile organic compounds (VOCs) in a person’s breath to detect diseases.
Combatting Obesity: Overcoming the Interplay of Factors
Obesity is far more complex than the chronic consumption of too many calories. Unraveling obesity’s origins and finding effective therapies requires navigating a…
Unlock the Language of Cells with Cell Signaling
In any multicellular organism, individual cells must communicate with each other through complicated cell signaling pathways. Since any…
Breaking Down Drug Metabolism
When popping a pill, how often do we think about what happens next—to the pill or our bodies? Maybe we assume the body welcomes any extra help to soothe our headaches or control our blood pressure. This article looks into the mystery of what comes after the swallow....
Swallowing a Biological Drug?
Over the past two decades, biological drugs — drugs composed of proteins produced by living cells — have become the safest, most effective top sellers within the pharmaceutical industry. Approved to treat a variety of diseases, including rheumatoid arthritis,...
Groundbreaking Migraine Drug Explained
In May 2018, the FDA approved Amgen’s (Thousand Oaks, CA) new migraine drug Aimovig, the first drug shown to prevent the onset of migraines. The drug significantly reduces the number of migraine days in difficult-to-treat (those that have failed 2 to 4 prior...
The Immune System: Friend & Sometimes Foe
The immune system. Yes, everybody has one. It’s pretty important to our health. But what the heck is it? In short, the immune system is a complicated network of organs, cells, and signaling molecules. Without this guardian, we fall prey to dangerous pathogens and...
Parp1 Inhibitor Takes on Pancreatic Cancer
PARP1 inhibitors are back in the headlines after Astra Zeneca’s (Cambridge, England) and Merck’s (Kenilworth, New Jersey) Lynparza approval by FDA to treat pancreatic cancer patients based on the positive Phase III results. Pancreatic cancer is a notoriously difficult...
Hope On The Horizon For Huntington’s
No question about it, Huntington’s disease (HD) is cruel. In the beginning, sufferers of this fatal neurodegenerative disorder experience involuntary movement and mood disturbance, most often in the form of depression. As the disease progresses, patients lose the...
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.